{"id":1000218,"date":"2026-09-03T08:34:59","date_gmt":"2026-09-03T12:34:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/"},"modified":"2026-09-03T08:34:59","modified_gmt":"2026-09-03T12:34:59","slug":"structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/","title":{"rendered":"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN FRANCISCO, Sept.  03, 2026  (GLOBE NEWSWIRE) &#8212; Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three upcoming healthcare conferences in September: <\/p>\n<p>\n        <strong>2026 Cantor Global Healthcare Conference<\/strong><br \/>\n        <br \/>Date: Thursday, September 10<br \/>Format: Fireside chat and 1&#215;1 meetings<br \/>Time: 3:55 \u2013 4:25 PM EDT<br \/>Location: New York, NY<\/p>\n<p>\n        <strong>Morgan Stanley 24<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference<\/strong><br \/>\n        <br \/>Date: Wednesday, September 16<br \/>Format: Fireside chat and 1&#215;1 meetings<br \/>Time: 10:45 \u2013 11:20 AM EDT<br \/>Location: New York, NY<\/p>\n<p>\n        <strong>Bernstein\u2019s 3rd Annual Healthcare Forum<\/strong><br \/>\n        <br \/>Date: Wednesday, September 23<br \/>Format: Fireside Chat and 1&#215;1 meetings<br \/>Time: 3:00 \u2013 3:40 PM EDT<br \/>Location: New York, NY<\/p>\n<p>The live and archived webcasts will be accessible from the company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rp1v8h3IdhLxNFJhp8gKFb7byucQiuQmvIY-Njq8u7YBgGCYG6JAXAiSs7ITQ3FV-9OkdUsDwMdyNAVfQAcAO_HHc_bCuI0OwRR1AwjtIg5cIr1f9XOojkWDV9f8O-wkUnX4kwMYB5AzFl3X98Q6PD1OAgYljJz2N_L18TVn5FdFo2K93CG4ENIv_wCbiMuzaNeVJ3z5PMdbzFEdOsL3fnv-Vx3_GbGuDM1DyMupPrsB3dMt4XaPW_nNOsQ9UsBEQSP6rYBfFf3uH-jo0E_rX0SYc385Hg5CeSOju_HEhuOuZT7WCt0IpmioeuHT7tVSvOiiOOXiTvEWaLq3aaU1AU73GEj8pFMUFaopd6WT_SVK23ntXFPrYH_ZMP8omdB4uEtUlFF0zeRigL5QSogne1sGNW06TXAifllQtwGQeLM=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.structuretx.com\/events-presentations\/events<\/a>\u00a0and replays will be available for at least 90 days.<\/p>\n<p>\n        <strong>About Structure Therapeutics<\/strong>\u00a0<br \/>Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage oral small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more people living with obesity around the world. For additional information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8sA1drefCeaVEtzWXHlajMiyk1fpMt0kUlgnzQqv5Bk2bs1chQax3v7PvzpAeE8O3bnBQ-IScZQgUsSnnN5ZZessrjqC99v9R4roMaQPPX0=\" rel=\"nofollow\" target=\"_blank\">www.structuretx.com<\/a>.<\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Corey Davis, Ph.D.<br \/>LifeSci Advisors, LLC<br \/>212-915-2577<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=W99jpBnkY84BjtiApzN74xTcabGHg8ILRmqh3ABrpYdq7BEd2SH_-_zrGHyMfXRRkNeB-2dt_ferULPQld4VKmjnvkC1njdxcZI4X1s4TqejXgmzy4fjjH39TbUy19v9\" rel=\"nofollow\" target=\"_blank\">cdavis@lifesciadvisors.com<\/a><\/p>\n<p>Jennifer Robinson<br \/>Structure Therapeutics Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E-sQ8BP4gHBu9bCn9ExnoiPdktWkcy8V4JJbD-mSKbQkaK-wVdYS0y60n3zPP6-BmBoWGav21r6GcTIC_FdK2F5j7yDkH6I8dzMMpJIt_vuNCXCcSGs-mq7K6PO8_MfRAYi3bKpd9g9XThMqjcGclQ==\" rel=\"nofollow\" target=\"_blank\">jennifer.robinson@structuretx.com<\/a><\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Dan Budwick<br \/>1AB<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kf95zk59icEkvTh3xrvr5EOhufeAfSDVjgpZda9GQAsfPfu-xlDVaHyboDCDIWoiYnZvRDuz6rRko8ZbOERhJmOGB7G-dhlQJcarP0yVLf4=\" rel=\"nofollow\" target=\"_blank\">Dan@1abmedia.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDMyZjI1ZDAtMzAyNi00YTU3LWJkZmYtM2IzMjJjYjg5ODQwLTEyNTc1OTEtMjAyNi0wOS0wMy1lbg==\/tiny\/Structure-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) &#8212; Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three upcoming healthcare conferences in September: 2026 Cantor Global Healthcare Conference Date: Thursday, September 10Format: Fireside chat and 1&#215;1 meetingsTime: 3:55 \u2013 4:25 PM EDTLocation: New York, NY Morgan Stanley 24 th Annual Global Healthcare Conference Date: Wednesday, September 16Format: Fireside chat and 1&#215;1 meetingsTime: 10:45 \u2013 11:20 AM EDTLocation: New York, NY Bernstein\u2019s 3rd Annual Healthcare Forum Date: Wednesday, September 23Format: Fireside Chat and 1&#215;1 meetingsTime: 3:00 \u2013 3:40 PM EDTLocation: New York, NY The live and archived webcasts will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1000218","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) &#8212; Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three upcoming healthcare conferences in September: 2026 Cantor Global Healthcare Conference Date: Thursday, September 10Format: Fireside chat and 1&#215;1 meetingsTime: 3:55 \u2013 4:25 PM EDTLocation: New York, NY Morgan Stanley 24 th Annual Global Healthcare Conference Date: Wednesday, September 16Format: Fireside chat and 1&#215;1 meetingsTime: 10:45 \u2013 11:20 AM EDTLocation: New York, NY Bernstein\u2019s 3rd Annual Healthcare Forum Date: Wednesday, September 23Format: Fireside Chat and 1&#215;1 meetingsTime: 3:00 \u2013 3:40 PM EDTLocation: New York, NY The live and archived webcasts will &hellip; Continue reading &quot;Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-03T12:34:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences\",\"datePublished\":\"2026-09-03T12:34:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/\"},\"wordCount\":255,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/\",\"name\":\"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=\",\"datePublished\":\"2026-09-03T12:34:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk","og_description":"SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) &#8212; Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three upcoming healthcare conferences in September: 2026 Cantor Global Healthcare Conference Date: Thursday, September 10Format: Fireside chat and 1&#215;1 meetingsTime: 3:55 \u2013 4:25 PM EDTLocation: New York, NY Morgan Stanley 24 th Annual Global Healthcare Conference Date: Wednesday, September 16Format: Fireside chat and 1&#215;1 meetingsTime: 10:45 \u2013 11:20 AM EDTLocation: New York, NY Bernstein\u2019s 3rd Annual Healthcare Forum Date: Wednesday, September 23Format: Fireside Chat and 1&#215;1 meetingsTime: 3:00 \u2013 3:40 PM EDTLocation: New York, NY The live and archived webcasts will &hellip; Continue reading \"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-03T12:34:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences","datePublished":"2026-09-03T12:34:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/"},"wordCount":255,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/","name":"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=","datePublished":"2026-09-03T12:34:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDUxMSM3ODE0NzcyIzIyNDYwMzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/structure-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1000218"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000218\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1000218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1000218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1000218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}